Dublin, Jan. 26, 2016 -- Research and Markets (http://www.researchandmarkets.com/research/n8vbnd/lyophilized) has announced the addition of the "Lyophilized Injectables to 2020" report to their offering.
The inherent instability of protein drugs is a limitation that has a direct impact on the drug delivery sector. Therapeutic proteins must either be stored under special conditions or formulated to retain their efficacy from the time of manufacture until they are dispensed. Liquid protein drugs require refrigeration until dispensed - a requirement referred to as the cold chain'. Alternatively, proteins can be formulated as powders (lyophilization). Lyophilized proteins must be reconstituted prior to injection. Lyophilized drugs are sold with reconstitution vial systems, or packaged in special injection devices (e.g., pens, needle-free injectors, two-part syringes) that allow reconstitution to take place in the device prior to injection.
What You Will Learn
- Provides detailed analysis of lyophilized drugs, as-supplied packaging and therapeutic indication
- Analyzes therapeutic demand drivers and evaluates lyophilized drugs in eleven therapeutic areas
- Analyzes lyophilization technologies and market development issues
- Provides market data and forecasts to 2020
- Profiles market participants, their product development activities, business strategies, and corporate alliances and affiliations
- Assesses the importance of technology and regulatory factors on commercialization and market access
Key Topics Covered:
1. Executive Summary
2. The Market Opportunity
- Delivery Market Dynamics
- The Economics of lyophilized Drugs
- What's Driving the Market for Lyophilized Drugs?
- The Trend toward Self-Administration
- Shifting Demographics
- Innovation in Disposable Device Designs
- Therapeutic Demand Drivers
- Competitive Landscape
- Risk Factors
3. Lyophilized Drugs - Primary Packaging
- Single Use Vials
- Point-of-Care Reconstitution
- Specialty Packaging
- Drugs for SC/IM Injection
- Drugs for Infusion
- Product Specific Devices
4. Lyophilized Drugs - Reconstitution and Delivery
- Prefilled Diluent Syringes
- Proprietary Reconstitution Devices
- Single Step Devices
- Multi-Step Devices
- Human Engineering/Ergonomics
5. Lyophilized Drugs - Key Therapeutic Sector Analysis and Market Data
- Antibiotics
- Autoimmune Diseases
- Blood Factors
- Hormones
- Infectious Diseases
- Metabolic Conditions
- Oncology
- Reproductive Health
- Other Important Therapeutic Classes
6. Market Factors
- Regulatory Issues
- Patient Compliance and Ease of Use
- Healthcare Economics
7. Company Profiles
For more information visit http://www.researchandmarkets.com/research/n8vbnd/lyophilized
About Research and Markets
Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
CONTACT: Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716


Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch
Nasdaq Proposes Fast-Track Rule to Accelerate Index Inclusion for Major New Listings
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports
TSMC Eyes 3nm Chip Production in Japan with $17 Billion Kumamoto Investment
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns
SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies
Tencent Shares Slide After WeChat Restricts YuanBao AI Promotional Links
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering
Washington Post Publisher Will Lewis Steps Down After Layoffs
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge 



